文献速递结核与非结核分枝杆菌

基于QuantiFERON上清液的宿主生物标志物预测结核患者家庭接触者进展为活动性结核病

QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients.
PubMed 文献 · Clin Infect Dis · 2023-01-01

研究利用14例进展为活动性结核病的家庭接触者和20例年龄性别匹配的非进展者的储存QuantiFERON上清液,检测45种细胞因子、趋化因子和生长因子。IP-10/CCL19比值预测进展的敏感性和特异性均为100%, cutoff 0.24时阳性预测值为100(95%CI 85.8-100)。

要点

  • IP-10/CCL19比值预测结核病进展的敏感性和特异性均达100%。
  • IP-10/CCL19比值 cutoff 0.24时阳性预测值为100(95%CI 85.8-100)。
  • IP-10、CCL19、IFN-γ、IL-1ra、CCL3和GM-CSF的AUC≥90。

核心结论

  • 本研究鉴定的生物标志物可为开发更准确的检测方法铺平道路,以识别立即进展为结核病高风险个体并进行针对性干预。

研究设计与样本

  • 使用14例在2年随访期间发生活动性结核病的指示病例家庭接触者和20例年龄性别匹配的非进展者的储存QuantiFERON上清液。
  • 采用Luminex Multiplex Array试剂盒检测45种细胞因子、趋化因子和生长因子。

主要发现

  • 进展者与非进展者之间多种分析物的结核抗原诱导产生水平存在显著差异。
  • 优势分析基于相对百分比重要性确定了15种关键预测生物标志物。
  • 主成分分析显示这些生物标志物能稳健区分两组。
  • 受试者工作特征分析确定IP-10、CCL19、IFN-γ、IL-1ra、CCL3和GM-CSF为最有前景的预测标志物,AUC≥90。
  • IP-10/CCL19比值预测进展的敏感性和特异性均达100%。

关键数值与推荐

  • 通过分类与回归树分析,IP-10/CCL19比值 cutoff 0.24预测短期进展为结核病的阳性预测值为100(95%CI 85.8-100)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The positive predictive value of tuberculin skin test and current generation interferon gamma release assays are very low leading to high numbers needed to treat. Therefore, it is critical to identify new biomarkers with high predictive accuracy to identify individuals bearing high risk of progression to active tuberculosis (TB). METHODS: We used stored QuantiFERON supernatants from 14 household contacts of index TB patients who developed incident active TB during a 2-year follow-up and 20 age and sex-matched non-progressors. The supernatants were tested for an expanded panel of 45 cytokines, chemokines, and growth factors using the Luminex Multiplex Array kit. RESULTS: We found significant differences in the levels of TB-antigen induced production of several analytes between progressors and non-progressors. Dominance analysis identified 15 key predictive biomarkers based on relative percentage importance. Principal component analysis revealed that these biomarkers could robustly distinguish between the 2 groups. Receiver operating characteristic analysis identified interferon-γ inducible protein (IP)-10, chemokine ligand (CCL)19, interferon (IFN)-γ, interleukin (IL)-1ra, CCL3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) as the most promising predictive markers, with area under the curve (AUC) ≥90. IP-10/CCL19 ratio exhibited maximum sensitivity and specificity (100%) for predicting progression. Through Classification and Regression Tree analysis, a cutoff of 0.24 for IP-10/CCL19 ratio was found to be ideal for predicting short-term risk of progression to TB disease with a positive predictive value of 100 (95% confidence interval [CI] 85.8-100). CONCLUSIONS: The biomarkers identified in this study will pave way for the development of a more accurate test that can identify individuals at high risk for immediate progression to TB disease for targeted intervention.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Daniel EA, Thiruvengadam K, Rajamanickam A, et al. QuantiFERON Supernatant-Based Host Biomarkers Predicting Progression to Active Tuberculosis Disease Among Household Contacts of Tuberculosis Patients. Clin Infect Dis. 2023. PMID: 36582115. doi:10.1093/cid/ciac979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。